Urovant Sciences
Company Description
Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.
Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions. Urovant’s lead therapeutic candidate is vibegron (RVT-901), an investigational oral β3-adrenergic agonist being developed for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
-
Manufacturer:
Science and Engineering -
Company Website:
-
Company E-mail:
-
Company Address:
BaselSwitzerland -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits